Developmental patterns of neuronal thread protein gene expression in Down syndrome

Journal of the Neurological Sciences

Volumn 135, Issue 2, 1996, Pages 118-125

  De La Monte, Suzanne M ^a,b,c   Xu, Yong Yao ^a,b   Hutchins, Grover M ^a,b   Wands, Jack R ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Central nervous system; Down syndrome; Neurofilament protein; Neuronal thread protein

Indexed keywords

NEUROFILAMENT PROTEIN;

ADOLESCENT; ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CHILD; CONTROLLED STUDY; DOWN SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0030043982     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(95)00257-3     Document Type: Article

References (29)

1. Ozturk M, de la Monte S, Gross J, Wands JR. (1989) Elevated levels of an exocrine pancreatic secretory protein in Alzheimer's disease brain. Proc Natl Acad Sci USA 86: 419-423.
2. Gross J, Carlson RT, Brauer AW, Margolies MN, Warshaw AL, Wands JR. (1985) Isolation, characterization, and distribution of an unusual pancreatic human secretory protein. J Clin Invest 76: 2115-2126.
3. de la Monte SM, Ozturk M, Wands JR. (1990) Enhanced expression of an exocrine pancreatic protein in Alzheimer's disease and the developing human brain. J Clin Invest 86: 1004-1013.
4. de la Monte SM, Wands JR. (1992) Neuronal thread protein overexpression in brains with Alzheimer's disease lesions. J Neurol Sci 113: 152-164.
5. de la Monte SM, Volicer L, Hauser SL, Wands JR. (1992) Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol, 32: 733-742.
6. Xu Y-Y, Wands JR, de la Monte SM. (1993) Characterization of thread proteins expressed in neuroectodermal tumors. Cancer Res, 53: 3823-3829.
7. Xu Y-Y, Wands JR, de la Monte SM. (1993) Thread protein expression in neuroectodermal tumor cell lines of central nervous system origin. J Neuropathol Exp Neurol, 52: 291 (Abstract).
8. McKee AC, Kosik KS, Kowall NW. (1991) Neuritic pathology and dementia in Alzheimer's disease. Ann Neurol, 30: 156-165.
9. De Kosky S, Scheff SW. (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol, 27: 457-463.
10. Masliah E, Cole G, Shimohama S, Hansen LA, DeTeresa R, Terry RD, Saitoh T. (1989) Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett, 103: 234-239.
11. Scheff SW, De Kosky ST, Price DA. (1990) Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging, 11: 29-37.
12. Onorato M, Connolly J, Kosik K, Whitehouse P, Perry G. (1987) Alteration of neuritic cytoarchitecture in Alzheimer disease. J Cell Biol, 105: 203.
13. Scheibel AB, Tomiyasu U. (1978) Dendritic sprouting in Alzheimer's presenile dementia. Exp Neurol, 60: 1-8.
14. Braak H, Braak E. (1988) Neuropil threads occur in dendrites of tangle-bearing nerve cells. Neuropathol Appl Neurobiol, 14: 39-44.
15. Ihara Y. (1988) Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease. Brain Res, 78: 459: 138-144.
16. de la Monte SM, Spratt RA, Chong J, Ghanbari HA, Wands JR. (1992) Immunohistochemical and histopathologic correlates of Alzheimer's disease-associated Alz-50 immunoreactivity quantified in homogenates of cerebral tissue. Am J Pathol, 141: 1459-1469.
17. de la Monte SM, Wands JR. Diagnostic utility of quantitating neurofilament immunoreactive Alzheimer's disease lesions. J Histochem Cytochem 1994 (In press).
18. Tabaton M, Mandybur TI, Perry G, Onorato M, Autilio-Gambetti L, Gambetti P. (1989) The widespread alteration of neuntes in Alzheimer's disease may be unrelated to amyloid deposition. Ann Neurol, 26: 771-778.
19. Lai F, Williams RS. (1989) A prospective study of Alzheimer disease in Down syndrome. Arch Neurol, 46: 849-853.
20. Mann DM, Jones D, Prinja D, Purkiss MS. (1990) The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down syndrome and Alzheimer's disease. Act Neuropathol (Berl), 80: 313-327.
21. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Van Belle G, Berg L, et al. (1991) Neurology, 41: 479-486.
22. Cammarata S, Mancardi G, Tabaton M. (1990) Formic acid treatment exposes hidden neurofilament and tau epitopes in abnormal cytoskeletal filaments from patients with progressive supranuclear palsy and Alzheimer's disease. Neurosci Lett, 115: 351-355.
23. Sasaki Y, Zhang XF, Nishiyama M, Avruch J, Wands JR. (1993) Expression and phosphorylation of insulin receptor substrate 1 during rat liver regeneration. J Biol Chem, 268: 3805-3808.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem., 193 (1951) 265-275.
25. Current Protocols in Molecular Biology. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. (Eds), John Wiley & Sons, New York, 1988.
26. Cork, L.C. (1990) Neuropathology of Down syndrome and Alzheimer disease. Am J. Med Genet, 7 (Suppl): 282-286.
27. Hyman, B.T. (1992) Down syndrome and Alzheimer disease. Prog Clin Biol Res, 379: 123-142.
28. Wolozin, B., Scicutella, A., Davies P. (1988) Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA, 85: 6202-6206.
29. Hussey S., Gibson, P.H., Elton R.A., Yates, C.M., Christie, J.E., Eagles, P.A., Gordon, A., (1988) Solubility of neurofibrillary tangles and ultrastructure of paired helical filaments in sodium dodecylsulphate. Acta Neuropathol (Berl) , 75: 1495-1501.